Skip to the answer

Perphenazine Uses, Dosage, Side Effects and Interactions

Brand name
Trilafon

Trilafon is a perphenazine brand from before 1982. The FDA now lists it as discontinued; generic perphenazine is still listed.

Perphenazine is an older antipsychotic (a phenothiazine) used to treat schizophrenia and to control severe nausea and vomiting in adults.

Dr. Brian Staiger, PharmD, BCPS
Last reviewed Jul 10, 2026 Content updated Nov 7, 2026 Where our facts come from

Quick links

Ask Anything About PerphenazineType a question in your own words. Answered from its FDA label in seconds.

Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.

Perphenazine in Short

The Pharmacist’s Take

Dr. Brian Staiger, PharmD, BCPS
Clinical pharmacist Written

Perphenazine (Trilafon) is an older phenothiazine antipsychotic for schizophrenia and severe nausea and vomiting in adults, a standby since the late 1950s with FDA-approved generics listed, though newer antipsychotics are prescribed more often. Most people manage it, though early drowsiness, dry mouth, constipation and lightheadedness on standing are common. It carries a boxed warning for higher risk of death in older adults with dementia-related psychosis, a use it is not approved for. Regular check-ins keep the dose low, since longer use raises the risk of tardive dyskinesia, repeated face, mouth or tongue movements that can be permanent.

Key Takeaways From the HelloPharmacist Team

  • Take it by mouth, usually a few times a day, and expect your prescriber to lower the dose once symptoms are controlled.
  • Expect drowsiness in the first week or two, so skip alcohol and hold off driving until you know how it affects you.
  • Get help fast for neck or jaw spasms or throat tightness in the first days, or fever with stiff muscles and confusion anytime.
  • Tell your prescriber if you take fluoxetine, sertraline, paroxetine or a tricyclic antidepressant, since these can raise perphenazine levels.

How we write and review this content: our editorial policy

FDA Boxed WarningThe FDA’s strongest safety alert. Read what it says about Perphenazine.

Older adults with dementia-related psychosis who take antipsychotics like perphenazine have a higher risk of death. In trials of about 10 weeks, about 4.5% of drug-treated patients died, compared with about 2.6% on placebo.

Most deaths were heart-related (such as heart failure or sudden death) or infections (such as pneumonia). Perphenazine is not approved to treat dementia-related psychosis. If you care for someone with dementia who takes it, talk with their prescriber.

Read the full warning on DailyMed →

Perphenazine by the Numbers

Strengths
4
in one form
Makers and packagers
16
Earliest FDA record
1957
Rank by Medicaid prescriptions
#587 of 1,682 drugs
More prescriptions than 65% of the 1,682 drugs we measure
66,429 prescriptions, Q1–Q4 2025

Patient Information Guide for Perphenazine

What It’s Used For

Perphenazine is used for these conditions in adults:

  • Schizophrenia
  • Severe nausea and vomiting

It has not been shown effective for behavioral complications in people with intellectual disability. Perphenazine tablets (oral, including the film-coated tablets) carry these uses.

How It Works

Perphenazine acts at all levels of the central nervous system, especially the hypothalamus. The exact site and mechanism behind its therapeutic effect are not known.

Drug Class

Drug Class

  • Phenothiazine
Detailed classifications and sources

The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class.

Drug Class

Established Pharmacologic Class (EPC)
  • Phenothiazine

The main drug class the FDA gives it. It is the class named on the drug’s label.

How It Works

Mechanism of action (MoA)

None listed for Perphenazine in the FDA’s index.

What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.

What It Does in the Body

Physiologic effect (PE)

None listed for Perphenazine in the FDA’s index.

From our Patient Information GuidePerphenazine acts at all levels of the central nervous system, especially the hypothalamus. The exact site and mechanism behind its therapeutic effect are not known. Read How Perphenazine Works

A change it makes in how the body works.

Chemical Family

Chemical structure (CS)
  • Phenothiazines

The chemical family it belongs to, by its structure.

Drug Family

WHO ATC classification
  • Phenothiazines with piperazine structure

How the World Health Organization groups it: by the part of the body it acts on and what it treats.

The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. The description under What It Does in the Body is written by the HelloPharmacist team, not the FDA. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.

Dosage

Perphenazine tablets are taken by mouth. Your prescriber individualizes the dose and aims for the lowest dose that works, since movement-related side effects increase with higher doses.

  • Dosing for schizophrenia is often several times a day at first, then lowered to the minimum effective amount.
  • For nausea and vomiting, the daily amount is split into divided doses, and early reduction is desirable.
  • Older adults usually start lower.
  • A dose may be taken at bedtime if needed.

Follow your prescriber and the pharmacy label.

Typical Doses

Your prescriber chooses your dose, so take it exactly as prescribed.

Schizophrenia

Moderately disturbed adults not in a hospital · Starting dose Starting dose 4 to 8 mg three times a day
  • 4 to 8 mg t.i.d. initially
  • Reduce as soon as possible to minimum effective dosage
Adults in a hospital Usual dose 8 to 16 mg two to four times a day Highest dose 64 mg a day
  • 8 to 16 mg b.i.d. to q.i.d.

b.i.d. means twice a day.

Severe nausea and vomiting

For adults
Usual dose 8 to 16 mg a day in divided doses
  • 24 mg occasionally may be necessary, early dosage reduction is desirable

Other Doses

Older adults Geriatric dosages have not been established; initiation of lower dosages is recommended. Optimal effect may require lower doses for a longer duration

Good to know

Plasma concentrations per daily ingested dose increase with increasing age

See the Full Dosing Instructions on DailyMed →

Side Effects

Common effects include:

Common side effects

  • Drowsiness, especially in the first week or two
  • Dizziness or lightheadedness when standing up
  • Dry mouth
  • Constipation
  • Blurred vision
  • Nasal congestion
  • Restlessness or muscle stiffness (extrapyramidal symptoms)
  • Increased appetite and weight gain
  • Dizziness and low blood pressure on standing
  • Restlessness, stiffness or tremor-like movement problems

When to get medical help

  • Call your doctor right away if you have fever, stiff muscles, confusion, irregular pulse or blood pressure, or heavy sweating. These can be signs of neuroleptic malignant syndrome, which can be fatal.
  • Tell your doctor about repeated or unusual movements of the tongue, face, mouth or jaw. These can be tardive dyskinesia, which may be permanent.
  • Get help for neck spasms, throat tightness, trouble swallowing or breathing, or tongue protrusion (dystonia), which can occur in the first few days.
  • Report a sudden sore throat or signs of infection, especially in weeks 4 to 10. These can signal a serious drop in white blood cells.
  • Report yellowing of the skin or eyes (jaundice), usually seen in weeks 2 to 4.
  • Seek care for seizures, fainting, or a very fast, slow or irregular heartbeat.
  • Tell your doctor about vision changes or skin pigment changes during long-term use.
  • Get emergency help for severe constipation or belly swelling, which can signal a bowel blockage (adynamic ileus).

Warnings and Precautions

  • Higher risk of death in older adults with dementia-related psychosis (boxed warning).
  • Tardive dyskinesia (uncontrolled movements) can be permanent.
  • Neuroleptic malignant syndrome is a rare, potentially fatal reaction.
  • Low white blood cell counts, mostly in weeks 4 to 10.
  • Falls and injuries from drowsiness and low blood pressure.
  • Impaired driving and machinery use.
  • Can lower the seizure threshold.

Interactions

These can change how perphenazine works or how safe it is:

  • Alcohol, barbiturates, narcotics, pain medicines and antihistamines in large amounts: added sedation, so avoid.
  • Tricyclic antidepressants, fluoxetine, sertraline and paroxetine: can raise perphenazine levels, so doses may need lowering.
  • Anticonvulsants: the anticonvulsant dose may need to increase.
  • Epinephrine: its effect is blocked, so it should not be used for low blood pressure.

Interactions Listed in the FDA-Approved Label

From the Perphenazine prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.

  • Drugs that inhibit P450 2D6, such as tricyclic antidepressants and selective serotonin reuptake inhibitors (fluoxetine, sertraline, paroxetine)
    What happensThey may acutely increase plasma concentrations of antipsychotics.
    What to doClose monitoring is essential and dose reduction may become necessary to avoid toxicity; lower doses than usually prescribed for either the antipsychotic or the other drug may be required.
  • Poor P450 2D6 metabolizers (about 10% of the Caucasian population)
    What happensThey have higher plasma concentrations of antipsychotic drugs at usual doses, which may correlate with side effects.
    What to doProspective phenotyping of elderly patients before antipsychotic treatment may identify those at risk for adverse events.
Read the label’s full interactions text

Drug Interactions Metabolism of a number of medications, including antipsychotics, antidepressants, ß-blockers, and antiarrhythmics, occurs through the cytochrome P450 2D6 isoenzyme (debrisoquine hydroxylase). Approximately 10% of the Caucasian population has reduced activity of this enzyme, so-called “poor” metabolizers. Among other populations the prevalence is not known. Poor metabolizers demonstrate higher plasma concentrations of antipsychotic drugs at usual doses, which may correlate with emergence of side effects. In one study of 45 elderly patients suffering from dementia treated with perphenazine, the 5 patients who were prospectively identified as poor P450 2D6 metabolizers had reported significantly greater side effects during the first 10 days of treatment than the 40 extensive metabolizers, following which the groups tended to converge. Prospective phenotyping of elderly patients prior to antipsychotic treatment may identify those at risk for adverse events. The concomitant administration of other drugs that inhibit the activity of P450 2D6 may acutely increase plasma concentrations of antipsychotics. Among these are tricyclic antidepressants and selective serotonin reuptake inhibitors, e.g., fluoxetine, sertraline and paroxetine. When prescribing these drugs to patients already receiving antipsychotic therapy, close monitoring is essential and dose reduction may become necessary to avoid toxicity. Lower doses than usually prescribed for either the antipsychotic or the other drug may be required.

Read the full Drug Interactions section on DailyMed →

Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.

Before You Start

  • Do not use if comatose or very hard to wake, or if you have blood disorders, bone marrow depression, or liver damage.
  • Do not use if you are allergic to perphenazine or related drugs.
  • Do not use with suspected or established subcortical brain damage.
  • Use caution with seizure disorders, alcohol withdrawal, depression, mitral insufficiency or pheochromocytoma.
  • Older adults need lower starting doses and are at higher risk of tardive dyskinesia.
  • Not recommended under age 12.
  • Pregnancy and breastfeeding: safety is not established, so benefits must be weighed against risks.

Overdose

Overdose can cause stupor or coma, severe movement side effects, and serious heart rhythm problems. Seizures can occur in children. Get emergency treatment right away and consider calling a poison center. There is no specific antidote, and care is supportive with heart monitoring.

Half-Life and How Your Body Processes It

After a tablet is taken by mouth, blood levels peak in about 1 to 3 hours. The half-life is about 9 to 12 hours, and steady levels are reached within about 72 hours of regular dosing. The liver breaks it down extensively, partly through the CYP2D6 enzyme. People with low CYP2D6 activity clear it more slowly and have higher levels.

Storage

Store at 20° to 25°C (68° to 77°F) .

Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Supplements and Herbs That Interact With Perphenazine

From the licensed clinical database we use, rolled up per supplement, most serious first.

145 supplements and herbal products have documented interactions with Perphenazine in the licensed clinical database we use.

Most are manageable, but your pharmacist should know about everything you take, including vitamins and herbals.

  • 5Major
  • 106Moderate
  • 34Minor

See the other 137

Educational information from a licensed clinical database (Natural Medicines). See our data sources and update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.

Perphenazine: Pharmacist Answers to Common Questions

Quick, plain-English answers to the questions patients ask most about Perphenazine — the kind of thing our pharmacy team would talk through with you at the counter.

What is perphenazine used for?

It treats schizophrenia and controls severe nausea and vomiting in adults. It has not been shown to help behavioral problems in people with intellectual disability.

Can I drink alcohol or drive while taking perphenazine?

Be careful. Perphenazine can make you drowsy and affect the skills needed for driving or machinery. It should not be combined with large doses of alcohol or other sedating drugs, so check with me or your doctor first.

What side effects should I expect?

Drowsiness is common early on, usually in the first week or two. Dry mouth, constipation, blurred vision, stuffy nose and dizziness when standing up can also happen. Tell your doctor if you notice restlessness, stiffness, or unusual movements.

When should I call my doctor right away?

Call for fever with stiff muscles and confusion, repeated movements of the tongue, face or jaw, a sudden sore throat or signs of infection, yellow skin or eyes, seizures, or fainting. Neck spasms or trouble swallowing or breathing need urgent help.

Is perphenazine safe for older adults?

Older adults usually start on lower doses because drug levels run higher with age. They also have a higher risk of tardive dyskinesia and falls. It carries a boxed warning for increased risk of death in older people with dementia-related psychosis, and it is not approved for that use.

Can I take perphenazine if I'm pregnant or breastfeeding?

Its safety in pregnancy and breastfeeding has not been established. Your doctor will weigh the benefits against the possible risks, so talk to them before you start or if you become pregnant.

Is perphenazine available over the counter?

No. Perphenazine is a prescription medicine: every perphenazine product listed with the FDA is prescription only, so it is not sold over the counter. Your prescriber decides whether it is appropriate for you, and your pharmacist dispenses it.

When was perphenazine first available?

The earliest FDA record we hold for perphenazine is from 1957: its first approval in Drugs@FDA or its earliest product listing in the NDC Directory, whichever is older. Many older medicines were in use before their first formal FDA approval, so this is the earliest date on record, not necessarily when perphenazine was first used.

Who makes perphenazine?

16 companies currently list perphenazine products in the FDA's NDC Directory, including Bryant Ranch Prepack, Remedyrepack Inc., Actavis Pharma, Inc.. That count includes repackagers and distributors as well as manufacturers (companies that sell only the raw ingredient are not counted), so fewer companies actually make it; the label on your bottle names the one that supplied yours.

What is the brand name of perphenazine?

Perphenazine is the generic name. Its brand name is Trilafon. Generic versions are listed under the name perphenazine.

What is the generic name of Trilafon?

The generic name of Trilafon is perphenazine. A generic name is the name of the active ingredient, the same whichever company makes the medicine; a brand name belongs to one company. Your prescription label may show either name.

What drug class is perphenazine?

Perphenazine belongs to the drug class Phenothiazine, its established pharmacologic class on the FDA label.

Is there a generic version of perphenazine?

Yes. FDA-approved generic versions of perphenazine are listed in the FDA's National Drug Code Directory. A listing does not prove that every pharmacy stocks one, so your pharmacy can tell you which version it carries.

What strengths does perphenazine come in?

Perphenazine is listed in the FDA's National Drug Code Directory in these forms and strengths. Tablet (by mouth): 2 mg, 4 mg, 8 mg and 16 mg. A listing does not mean every pharmacy stocks every strength.

How much does perphenazine cost?

What you pay depends on your insurance, your pharmacy and the strength you take. As a benchmark, pharmacies paid a national average of $0.13 to $0.36 per generic tablet across 4 strengths as of November 18, 2026 (CMS's NADAC survey). That is the pharmacy's own cost for the medicine, not the price at the counter. The pharmacy prices section of this page lists every strength priced.

Is there a perphenazine shortage?

No. Perphenazine is not on the FDA's drug shortage list as of Nov 21, 2026. A single pharmacy can still run short for a while without a national shortage, and your pharmacist can tell you what they are seeing.

Where can I read the perphenazine prescribing information (package insert)?

The full FDA-approved prescribing information for perphenazine, also called the package insert or drug label, is published on DailyMed, the National Library of Medicine's library of FDA labels. Each company's version has its own label; this page is built from Rising Pharma Holdings, Inc.'s, revised Dec 12, 2024, and links to it on DailyMed.

Is perphenazine gluten free?

No perphenazine label we read lists an ingredient made from wheat, barley or rye, the grains that carry gluten, and none names a starch, dextrin or maltodextrin without saying where it comes from. We read the FDA labels of 73 perphenazine products from 16 companies. A label lists ingredients; it is not a gluten test, so we cannot promise that any product has no gluten. If you have celiac disease, ask the company for a written gluten statement. Our Inactive Ingredient Checker shows each company's perphenazine by strength and NDC, and whether its label lists a gluten source, lactose, dyes or any other inactive ingredient. See perphenazine inactive ingredients by company

Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Ask Anything About Perphenazine

Skip the scrolling. Ask in your own words and get an answer from Perphenazine’s FDA label and our pharmacists’ own work.

Try:

Name another drug or a supplement in your question and we check both.

AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
  • Sources: Perphenazine’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
  • Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
  • Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
  • Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.

More About Perphenazine on HelloPharmacist

Still have a question? A licensed pharmacist answers for free, usually within a day.
Detailed Data & References for Perphenazine Forms and strengths, pricing, billing codes, manufacturers, safety reports and sourcing: the data behind the page. Most people can stop here. Each section below opens on a tap.

Perphenazine Forms and Strengths (How It Comes)

Perphenazine comes in 1 dose form, the tablet. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.

Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Perphenazine inactive ingredients by manufacturer.

Tablet

By mouth
Brands Trilafon (before 1982, discontinued)
How this form is used
What it may be used for
  • Perphenazine tablets are used to treat schizophrenia.
  • Perphenazine tablets are used to control severe nausea and vomiting in adults.
Important instructions
  • Perphenazine tablets are taken by mouth, with the dose individualized to your condition and response.
  • Perphenazine tablets may be dosed before bedtime if needed.
  • Perphenazine tablets in older adults are generally started at lower doses.
Available strengths 4 strengths
73 FDA-listed product records ⓘ

Perphenazine on the U.S. Market: Products, Makers and Brands

How Perphenazine appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.

16 companies list 73 Perphenazine product records with the FDA, mostly as tablet; the earliest marketing or approval year on record is 1957.

1
Dose forms ⓘ
16
Labelers (makers, repackagers, distributors)
1
Brand names ⓘ
73
FDA-listed product records ⓘ
1957
Earliest FDA record ⓘ

Also listed with the FDA, not a patient dose form: Unfinished tablet, film coated (4) · Powder (3) — bulk drug substance and unfinished product sold to compounders and other manufacturers to finish, and multi-item kits. These aren’t counted in the dose-form total above.

Bryant Ranch Prepack19%
Remedyrepack Inc.12%
Actavis Pharma, Inc.5%
Endo USA, Inc.5%
Golden State Medical Supply, Inc.5%
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.5%
Other makers47%

Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

How Widely Perphenazine Is Used (Medicaid Data)

How many Perphenazine prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.

66,429
Medicaid prescriptions filled (Q1–Q4 2025)
$1.8M paid by Medicaid, before rebates

How commonly is Perphenazine prescribed? Of the 1,682 medications we measure, Perphenazine ranks #587 by Medicaid prescriptions — more than 65% of them.

Where Perphenazine ranks among the drugs we measure · Q1–Q4 2025 · neighbors ±5

Utilization by Perphenazine product

Pick a strength and form to see its own numbers. Brand and generic versions are counted together.

The 8 mg oral tablet is the most-dispensed Perphenazine product — about 36% of these Medicaid prescriptions.

perphenazine 8 MG Oral Tablet Most dispensed

23,993 Medicaid prescriptions (Q1–Q4 2025) 36% of Perphenazine prescriptions shown $649,909 paid by Medicaid, before rebates ≈ $27 per prescription, before rebates

9 of 46 listed NDCs had Medicaid claims. RxNorm 198078

perphenazine 4 MG Oral Tablet

22,408 Medicaid prescriptions (Q1–Q4 2025) 34% of Perphenazine prescriptions shown $540,073 paid by Medicaid, before rebates ≈ $24 per prescription, before rebates

9 of 43 listed NDCs had Medicaid claims. RxNorm 198077

perphenazine 2 MG Oral Tablet

10,484 Medicaid prescriptions (Q1–Q4 2025) 16% of Perphenazine prescriptions shown $219,247 paid by Medicaid, before rebates ≈ $21 per prescription, before rebates

9 of 43 listed NDCs had Medicaid claims. RxNorm 198076

perphenazine 16 MG Oral Tablet

9,544 Medicaid prescriptions (Q1–Q4 2025) 14% of Perphenazine prescriptions shown $351,821 paid by Medicaid, before rebates ≈ $37 per prescription, before rebates

8 of 45 listed NDCs had Medicaid claims. RxNorm 198075

Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.

Source: Medicaid State Drug Utilization Data (CMS), all states. 35 of the 177 listed Perphenazine NDCs had Medicaid claims.

Compare Perphenazine Products

A representative set of FDA-listed product records for Perphenazine — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)

Showing 73 of 73 products — FDA National Drug Code Directory. See every product, package size and price: browse all 73 Perphenazine NDCs →

Perphenazine Recall History

A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.

The FDA’s enforcement reports list no Perphenazine recalls since July 2021.

✅No Perphenazine recalls on record since July 2021

Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.

Perphenazine in RxNorm: From Ingredient to Every Form and Strength

RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one ingredient (IN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. Combination products are separate concepts with their own pages.

Dose forms
2
Strengths
6
Forms in current FDA listings
1 of 2
In current FDA listings No current FDA listing
Ingredient (IN) Perphenazine RxCUI 8076
  1. Dose form (SCDF) Oral Solution RxCUI 373296
    No current FDA listing
    Its 2 strengths (SCD)
    • 0.4 mg/mL RxCUI 108874
    • 0.8 mg/mL RxCUI 108875
  2. Dose form (SCDF) Oral Tablet RxCUI 373299
    In current FDA listings
    Its 4 strengths (SCD)

RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.

What Perphenazine Costs Pharmacies (NADAC Benchmark)

What pharmacies pay to buy Perphenazine: the national average from CMS’s weekly NADAC survey, as of Nov 18, 2026. It is the pharmacy’s cost, not your price at the counter.

How the Pharmacy Price Has Changed

Pick a strength to see how its price has changed since Nov 2023.

Strength

For the generic 2 mg tablet, pharmacies paid an average of $0.156 per tablet as of Nov 18, 2026, down 15% from $0.183 a year earlier.

What pharmacies pay now
$0.156
per tablet, as of Nov 18, 2026
Last 4 weeks
Down 9.3%
from $0.172 on Oct 21, 2026
Last 12 months
Down 15%
from $0.183 on Nov 19, 2025
Lowest and highest since Nov 2023
$0.147 to $0.238
per tablet

Each step is one weekly survey. Arrow keys on the chart move week by week.
See the numbers, month by month
Generic 2 mg tablet: the average pharmacy price per tablet, the last survey of each month
MonthPharmacy price
Nov 2026$0.156
Oct 2026$0.172
Sep 2026$0.197
Aug 2026$0.206
Jul 2026$0.207
Jun 2026$0.195
May 2026$0.185
Apr 2026$0.189
Mar 2026$0.200
Feb 2026$0.197
Jan 2026$0.184
Dec 2025$0.161
Nov 2025$0.183
Oct 2025$0.193
Sep 2025$0.217
Aug 2025$0.192
Jul 2025$0.180
Jun 2025$0.187
May 2025$0.204
Apr 2025$0.202
Mar 2025$0.177
Feb 2025$0.162
Jan 2025$0.178
Dec 2024$0.198
Nov 2024$0.220
Oct 2024$0.203
Sep 2024$0.212
Aug 2024$0.166
Jul 2024$0.190
Jun 2024$0.173
May 2024$0.166
Apr 2024$0.151
Mar 2024$0.238
Feb 2024$0.170
Jan 2024$0.147
Dec 2023$0.217
Nov 2023$0.219
FormStrengthVersion What pharmacies pay
Tablet · Oral 2 mg Generic $0.156 per tablet NDC details & price history
Tablet · Oral 4 mg Generic $0.169 per tablet NDC details & price history
Tablet · Oral 8 mg Generic $0.129 per tablet NDC details & price history
Tablet · Oral 16 mg Generic $0.356 per tablet NDC details & price history
Why it helps: it shows whether the drug itself is cheap or costly, and whether a cash price you are quoted is in a reasonable range. What you pay also depends on your insurance and pharmacy.

Source: CMS National Average Drug Acquisition Cost (NADAC). Each row spans the package sizes CMS priced; the generic and the brand are priced separately.

Perphenazine Brand Names

Perphenazine has one brand name on record: Trilafon. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.

Trilafon before 1982, discontinued

Who Makes Perphenazine: Manufacturers and Labelers

16 companies list Perphenazine products with the FDA. By number of product records, the largest are Bryant Ranch Prepack, Remedyrepack Inc., Actavis Pharma, Inc.. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.

Bryant Ranch Prepack 14 Remedyrepack Inc. 9 Actavis Pharma, Inc. 4 Endo USA, Inc. 4 Golden State Medical Supply, Inc. 4 Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 4 Macleods Pharmaceuticals Limited 4 Proficient Rx LP 4 Rising Pharma Holdings, Inc. 4 Sandoz Inc 4 Wilshire Pharmaceuticals, Inc. 4 Zydus Lifesciences Limited 4 Zydus Pharmaceuticals (USA) Inc. 4 Major Pharmaceuticals 3 American Health Packaging 2 Chartwell RX, LLC 1

Sources for This Perphenazine Page

Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.

📄
FDA-filed drug labels (SPL) Uses, dosing, warnings & side effects from SPL records retrieved through openFDA; the linked representative set can be verified on DailyMed. Prescribing information dated Dec 12, 2024, the label version this page reads. A label changes when the FDA approves new uses, doses or warnings, so this is not the day the page itself last changed. Read the full label on DailyMed
🏭
Forms, brands & labelersAggregated from ingredient-matched FDA National Drug Code Directory product records for Perphenazine.
📈
Real-world reportsThe FDA Adverse Event Reporting System (FAERS), served through openFDA.
🚨
Recalls & shortagesopenFDA drug-enforcement reports and the FDA drug-shortage database.

Where this information comes from

The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 38 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source.

Clinical labels in scope
38
Finished products in the current FDA directory
73
Companies listing them (makers, repackagers, distributors)
16
FDA labeler codes behind them ⓘ
18
Linked representative label ⓘ
Rising Pharma Holdings, Inc.
Linked label effective
Dec 12, 2024
Composite sections available
17
Linked SPL Set ID
0ebf4c11-1810-42f6-a8e3-071616e33d5d
Linked SPL Document ID
87116aca-1278-4b75-a579-deba407a3129
Open the linked representative label on DailyMed ↗

How this page is built

HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Rising Pharma Holdings, Inc. is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →